Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

43
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
43
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

544
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
544
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

28
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
28
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

38
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
38
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

640
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
640
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

65
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
65

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Destress II: using the Behaviour Change Wheel and preliminary testing to co-develop a complex intervention to improve the quality of primary care responses to people experiencing poverty-related mental distress.

BMC primary care·2026
Same author

Effects of active travel interventions in the UK on disadvantaged population groups and their potential to reduce health inequalities: systematic review.

Journal of epidemiology and community health·2026
Same author

Associations of cannabis use, tobacco use and co-use with brain volume: A systematic review and meta-analysis.

Addiction (Abingdon, England)·2026
Same author

Optimising the European Code Against Cancer, 5th edition, to increase awareness of avoidable cancer risks in all socioeconomic groups.

Molecular oncology·2026
Same author

The Lancet Commission on improving population health post-COVID-19.

Lancet (London, England)·2025
Same author

Comparing the impact and mechanistic pathways of micro-environmental interventions targeting healthier vs. more environmentally sustainable food options: an overview of reviews.

BMC medicine·2025

Related Experiment Video

Updated: Oct 28, 2025

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

14.5K

Cigarette pack size and consumption: an adaptive randomised controlled trial.

Ilse Lee1, Anna K M Blackwell2, Michelle Scollo3

  • 1Behaviour and Health Research Unit, University of Cambridge, Cambridge, CB2 0SR, UK.

BMC Public Health
|July 19, 2021
PubMed
Summary

Reducing cigarette pack sizes did not significantly decrease daily smoking in this trial. Further research is needed to confirm if smaller pack sizes effectively reduce cigarette consumption.

Keywords:
Adaptive designCigarette packagingPack sizeTobacco control

More Related Videos

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.4K
Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

11.3K

Related Experiment Videos

Last Updated: Oct 28, 2025

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

14.5K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.4K
Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

11.3K

Area of Science:

  • Public Health
  • Tobacco Control
  • Behavioral Science

Background:

  • Observational studies link cigarette pack size to consumption, but experimental evidence is lacking.
  • The tobacco industry is increasing pack sizes, with Australian packs ranging up to 50 cigarettes.
  • Regulation of maximum cigarette pack size is absent.

Purpose of the Study:

  • To estimate the impact of reducing cigarette pack sizes from 25 or more cigarettes to 20 cigarettes per pack on smoking consumption.
  • To provide experimental evidence on the causal relationship between cigarette pack size and smoking behavior.

Main Methods:

  • A two-stage adaptive parallel group randomized controlled trial (RCT) was conducted with Australian smokers.
  • Participants were randomized to receive either 20-cigarette packs (intervention) or their usual larger packs (control) for four weeks.
  • The primary outcome was the average number of cigarettes smoked per day, measured by collecting used packs.

Main Results:

  • An interim analysis indicated a need for 1122 additional participants, exceeding recruitment feasibility, leading to early termination.
  • Analysis of the 79 participants showed a mean of 15.9 cigarettes/day in the intervention group versus 16.8 in the control group.
  • The difference in mean daily consumption was -0.9 cigarettes (95% CI: -4.3, 2.6), which was not statistically significant.

Conclusions:

  • It remains unclear if reducing cigarette pack sizes to 20 cigarettes decreases consumption.
  • The study provides no evidence that capping pack sizes is ineffective for smoking reduction.
  • Limitations highlight the need for a more efficient RCT to address the lack of experimental evidence on large pack sizes.